WO2011035945A3 - Use of a combination of carnitine and/or a carnitine derivative with purine and/or a purine derivative for influencing the natural pigmentation process - Google Patents

Use of a combination of carnitine and/or a carnitine derivative with purine and/or a purine derivative for influencing the natural pigmentation process Download PDF

Info

Publication number
WO2011035945A3
WO2011035945A3 PCT/EP2010/060032 EP2010060032W WO2011035945A3 WO 2011035945 A3 WO2011035945 A3 WO 2011035945A3 EP 2010060032 W EP2010060032 W EP 2010060032W WO 2011035945 A3 WO2011035945 A3 WO 2011035945A3
Authority
WO
WIPO (PCT)
Prior art keywords
carnitine
purine
derivative
influencing
combination
Prior art date
Application number
PCT/EP2010/060032
Other languages
German (de)
French (fr)
Other versions
WO2011035945A2 (en
Inventor
Melanie Giesen
Erik Schulze Zur Wiesche
Edo Hoting
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP10731525A priority Critical patent/EP2480195A2/en
Publication of WO2011035945A2 publication Critical patent/WO2011035945A2/en
Publication of WO2011035945A3 publication Critical patent/WO2011035945A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the use of a combination of carnitine and/or a carnitine derivative with purine and/or a purine derivative for influencing the natural pigmentation process of the skin and/or cutaneous appendages.
PCT/EP2010/060032 2009-09-24 2010-07-13 Use of a combination of carnitine and/or a carnitine derivative with purine and/or a purine derivative for influencing the natural pigmentation process WO2011035945A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10731525A EP2480195A2 (en) 2009-09-24 2010-07-13 Use of a combination of carnitine and/or a carnitine derivative with purine and/or a purine derivative for influencing the natural pigmentation process

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200910044964 DE102009044964A1 (en) 2009-09-24 2009-09-24 Use of a combination of carnitine and / or a carnitine derivative with purine and / or a purine derivative for influencing the natural pigmentation process
DE102009044964.7 2009-09-24

Publications (2)

Publication Number Publication Date
WO2011035945A2 WO2011035945A2 (en) 2011-03-31
WO2011035945A3 true WO2011035945A3 (en) 2011-12-01

Family

ID=43383484

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/060032 WO2011035945A2 (en) 2009-09-24 2010-07-13 Use of a combination of carnitine and/or a carnitine derivative with purine and/or a purine derivative for influencing the natural pigmentation process

Country Status (3)

Country Link
EP (1) EP2480195A2 (en)
DE (1) DE102009044964A1 (en)
WO (1) WO2011035945A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009044964A1 (en) 2009-09-24 2011-03-31 Henkel Ag & Co. Kgaa Use of a combination of carnitine and / or a carnitine derivative with purine and / or a purine derivative for influencing the natural pigmentation process
DE102010043069A1 (en) * 2010-10-28 2012-05-03 Henkel Ag & Co. Kgaa Use of purine and / or a purine derivative and at least one amino acid for influencing the natural pigmentation process
DE102010043068A1 (en) * 2010-10-28 2012-05-03 Henkel Ag & Co. Kgaa Use of purine and / or a purine derivative and at least one biochinone for influencing the natural pigmentation process
DE102014212921A1 (en) 2014-07-03 2016-01-07 Henkel Ag & Co. Kgaa Use of specific oligopeptides to stimulate the natural pigmentation process in skin appendages

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007945A1 (en) * 1989-11-28 1991-06-13 Lvmh Recherche Utilization of xanthines, optionally incorporated in liposomes in order to help the pigmentation of skin or hair
US5591423A (en) * 1989-12-15 1997-01-07 The Board Of Regents Of The University Of Oklahoma Pigmentation enhancer and method
WO2002102338A1 (en) * 2001-06-19 2002-12-27 Beiersdorf Ag Carnitine and acyl-carnitines used in the treatment and prophylaxis of pigmentation disorders
DE10150412A1 (en) * 2001-10-11 2003-04-17 Beiersdorf Ag Purines or pyrimidines are used in cosmetics or dermatological compositions used in intensifying natural skin tanning or in stimulating melanogenesis in human skin
WO2006097205A2 (en) * 2005-03-14 2006-09-21 Henkel Kommanditgesellschaft Auf Aktien Method for conducting extracorporeal analysis of hair follicle cells
EP1927378A1 (en) * 2006-11-29 2008-06-04 Henkel Kommanditgesellschaft auf Aktien Hair-treatment compositions comprising quercetin and use thereof to revitalize hair
DE102006062438A1 (en) * 2006-12-27 2008-07-03 Henkel Kgaa Cosmetic or dermatological composition, useful e.g. in the topical treatment of the skin, comprises an aporphine-alkaloids and a further active agent of e.g. purine, natural betaine compounds, monomer, oligomer or polymer of aminoacid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725030A1 (en) 1987-07-29 1989-02-09 Henkel Kgaa SURFACE ACTIVE HYDROXYSULFONATE
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4413686C2 (en) 1994-04-20 1996-10-24 Henkel Kgaa Cationic sugar surfactants, process for their preparation and their use
US20010041187A1 (en) 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
ITRM20010044A1 (en) 2001-01-29 2002-07-29 Sigma Tau Healthscience Spa SLIMMING FOOD SUPPLEMENT.
DE102009044964A1 (en) 2009-09-24 2011-03-31 Henkel Ag & Co. Kgaa Use of a combination of carnitine and / or a carnitine derivative with purine and / or a purine derivative for influencing the natural pigmentation process

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007945A1 (en) * 1989-11-28 1991-06-13 Lvmh Recherche Utilization of xanthines, optionally incorporated in liposomes in order to help the pigmentation of skin or hair
US5591423A (en) * 1989-12-15 1997-01-07 The Board Of Regents Of The University Of Oklahoma Pigmentation enhancer and method
WO2002102338A1 (en) * 2001-06-19 2002-12-27 Beiersdorf Ag Carnitine and acyl-carnitines used in the treatment and prophylaxis of pigmentation disorders
DE10150412A1 (en) * 2001-10-11 2003-04-17 Beiersdorf Ag Purines or pyrimidines are used in cosmetics or dermatological compositions used in intensifying natural skin tanning or in stimulating melanogenesis in human skin
WO2006097205A2 (en) * 2005-03-14 2006-09-21 Henkel Kommanditgesellschaft Auf Aktien Method for conducting extracorporeal analysis of hair follicle cells
EP1927378A1 (en) * 2006-11-29 2008-06-04 Henkel Kommanditgesellschaft auf Aktien Hair-treatment compositions comprising quercetin and use thereof to revitalize hair
DE102006062438A1 (en) * 2006-12-27 2008-07-03 Henkel Kgaa Cosmetic or dermatological composition, useful e.g. in the topical treatment of the skin, comprises an aporphine-alkaloids and a further active agent of e.g. purine, natural betaine compounds, monomer, oligomer or polymer of aminoacid

Also Published As

Publication number Publication date
WO2011035945A2 (en) 2011-03-31
EP2480195A2 (en) 2012-08-01
DE102009044964A1 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
WO2011009759A3 (en) Use of dihydroquercetin and at least one amino acid to positively influence the natural pigmentation process
EP2324064A4 (en) Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
WO2009154463A3 (en) Butyrate as a medicament to improve visceral perception in humans
SI2414363T1 (en) 1-heterocyclyl-1,5-dihydro-pyrazološ3,4-dćpyrimidin-4-one derivatives and their use as pde9a modulators
EP2461765A4 (en) Cosmetic skin rejuvination
EP2432933A4 (en) Method of producing and the use of microfibrillated paper
AU329314S (en) Comestible
EP2358452A4 (en) Doll with dress that transforms to wings
EP2526227A4 (en) Antimicrobial tissue paper and process to manufacture same
AU329878S (en) Shower head
AU329313S (en) Comestible
ZA201200608B (en) L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin
WO2011035945A3 (en) Use of a combination of carnitine and/or a carnitine derivative with purine and/or a purine derivative for influencing the natural pigmentation process
WO2011009758A3 (en) Use of purine and/or a purine derivative and at least one oligonucleotide to influence the natural pigmentation process
WO2011009763A3 (en) Cosmetic containing purine and/or a purine derivative and sclareol
AU329315S (en) Comestible
WO2011009757A3 (en) Use of human beta-defensin to influence the natural pigmentation process
WO2011009761A3 (en) Use of carnitine and dihydroquercitin to positively influence the natural pigmentation process
EP2421552B8 (en) Collagen v for use in the treatment of asthma
WO2012055580A3 (en) Use of purine and/or a purine derivative and at least one biochinone for influencing the natural pigmentation process
GB0821594D0 (en) Improvements in or relating to the treatment of tissue damage
ZA201005770B (en) The treatment of damaged skin
GB0814043D0 (en) The treatment of skin disorders
WO2013171202A3 (en) Use of a chaste tree extract for preparing a cosmetic and/or dermatological composition
AU322084S (en) Bread roll

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10731525

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010731525

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE